- Home
- TRDA vs FBYD Comparison
TRDA vs FBYD Comparison
Compare TRDA & FBYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRDA
- FBYD
- Stock Information
- Founded
- TRDA 2016
- FBYD 2021
- Country
- TRDA United States
- FBYD United States
- Employees
- TRDA N/A
- FBYD N/A
- Industry
- TRDA Biotechnology: Pharmaceutical Preparations
- FBYD
- Sector
- TRDA Health Care
- FBYD
- Exchange
- TRDA Nasdaq
- FBYD Nasdaq
- Market Cap
- TRDA 233.5M
- FBYD 263.6M
- IPO Year
- TRDA 2021
- FBYD N/A
- Fundamental
- Price
- TRDA $5.55
- FBYD $13.47
- Analyst Decision
- TRDA Strong Buy
- FBYD
- Analyst Count
- TRDA 3
- FBYD 0
- Target Price
- TRDA $25.67
- FBYD N/A
- AVG Volume (30 Days)
- TRDA 313.7K
- FBYD 43.6K
- Earning Date
- TRDA 11-04-2025
- FBYD 11-13-2025
- Dividend Yield
- TRDA N/A
- FBYD N/A
- EPS Growth
- TRDA N/A
- FBYD N/A
- EPS
- TRDA N/A
- FBYD 0.43
- Revenue
- TRDA $79,476,000.00
- FBYD $7,688,000.00
- Revenue This Year
- TRDA N/A
- FBYD N/A
- Revenue Next Year
- TRDA N/A
- FBYD N/A
- P/E Ratio
- TRDA N/A
- FBYD $32.12
- Revenue Growth
- TRDA N/A
- FBYD 9.17
- 52 Week Low
- TRDA $4.93
- FBYD $3.62
- 52 Week High
- TRDA $21.79
- FBYD $16.35
- Technical
- Relative Strength Index (RSI)
- TRDA 52.22
- FBYD 80.88
- Support Level
- TRDA $5.08
- FBYD $7.47
- Resistance Level
- TRDA $5.49
- FBYD $9.54
- Average True Range (ATR)
- TRDA 0.30
- FBYD 1.76
- MACD
- TRDA 0.03
- FBYD 0.65
- Stochastic Oscillator
- TRDA 72.11
- FBYD 71.81
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.
About FBYD Falcon's Beyond Global Inc.
Falcons Beyond Global Inc. is a Company that provides a full range of theme park design, master planning, and experiential technologies for customers in the entertainment and attraction industry through its Falcon's Creative Group reportable segment and develops and co-owns resort and theme park attractions through its Destinations Operations. The Company has four operating segments, Falcon's Creative Group, PDP, Falcon's Beyond Brands, and Destinations Operations, all of which are reportable segments. It earns the majority of the revenue from Falcon's Creative Group segment.